ESMO interviews Fortunato Ciardiello, MD, PhD about the use of Vorinostat in patients with advanced pleural mesothelioma (VANTAGE 014): urgent need to identify new drugs to face peak of cases in 10 years. www.esmo.org Interview by the European Society for Medical Oncology.
http://www.youtube.com/watch?v=QHByz2fkgfc&hl=en
Friends Link : netbook
0 comments:
Post a Comment